"I6 passages: on the reproduction of a human embryonic stem cell line from Israel to France".
Publication Date
2018Journal Title
New Genet Soc
ISSN
1463-6778
Publisher
Informa UK Limited
Volume
37
Issue
4
Pages
338-361
Language
eng
Type
Article
This Version
VoR
Physical Medium
Electronic-eCollection
Metadata
Show full item recordCitation
Merleau-Ponty, N. A. R., Vertommen, S., & Pucéat, M. (2018). "I6 passages: on the reproduction of a human embryonic stem cell line from Israel to France".. New Genet Soc, 37 (4), 338-361. https://doi.org/10.1080/14636778.2018.1548269
Abstract
The first French clinical trial using human embryonic stem cells for regenerative purposes was launched in 2014, using the I6 stem cell line that was imported from Israel. From Israel to France, national reproductive policies and practices inform how basic scientists produce, manage and circulate cells across countries. Building on an interdisciplinary co-production involving two social scientists and a life scientist, this article suggests that biobanks passage cells from in vitro fertilization to stem cell science and from country to country by modifying their reproductive meaning. Four passages are described: the absence of cells in 2005 when the research started in France; the presence of supernumerary embryos available for research in Israeli IVF biobanks; the production of the I6 stem cell bank in Israel; the importation and laboratory biobanking of the cells in France. Human embryonic stem cell lines can never be completely disentangled from reproduction.
Sponsorship
Wellcome Trust Grant no. 100606
H2020 Marie Skłodowska-Curie Actions
Fondation Fyssen
Funder references
Wellcome Trust (100606/Z/12/Z)
Embargo Lift Date
2100-01-01
Identifiers
External DOI: https://doi.org/10.1080/14636778.2018.1548269
This record's URL: https://www.repository.cam.ac.uk/handle/1810/286894
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.